Anju Mathew is a prominent figure in the healthcare industry with a passion for improving cancer care.

She is the CEO and co-founder of OncoLens, an award-winning company that provides innovative solutions for tumor board management, survivorship care planning, accreditation, and quality improvement.

Anju's background includes serving in key roles at McKesson's Medical Surgical unit, where she led technology and innovation initiatives and played a part in developing successful tools and partnerships.

Prior to OncoLens, she founded LumaMed, a medical device company focused on cancer imaging, and has also worked with renowned organizations like Thomson-Reuters, A. T. Kearney, IBM, and i2 Technologies.

Anju Mathew is an advocate for entrepreneurship and innovation, contributing to the Atlanta Technology Angels group and serving on the board of directors for Illuma Care Connections.

She holds an MBA with a focus on Strategy and Marketing from Northwestern University - Kellogg School of Management, as well as a BE in Industrial Engineering from the Indian Institute of Technology, Roorkee.